Drug leviatin, originally intended for HIV therapy can be an effective tool in the fight against Alzheimer's disease and other ailments. It is also used in the treatment of hepatitis B.
Experiments with human cells and live rodents demonstrated that the drug significantly reduced the level of inflammation associated with aging.
Moreover, experts suggest that leviatin theoretically able to play a key role not only in the treatment of Alzheimer's disease, but also to prevent the development of diabetes of the 2nd type, as well as such ailments as arthritis and macular degeneration.
During the experiments, leviatin introduced old rodents. In just two weeks, there have been positive trends in the issue of reducing inflammation. And for six months, the rodents have stopped losing the fat and muscle tissue and stop scarring of the kidneys.
Scientists from brown University say that older people are more susceptible to various kinds of inflammation. The principle of operation of livemedia is the blocking of retrotransposons, the genetic elements responsible for the changes in DNA that, in turn, provoke various ailments. The retrotransposons present in all tissue types. Thus, a medication can become a versatile tool in the fight against age-related diseases.